Table 2. Median sum of volumes of target angiomyolipoma lesions at baseline, EOT, and week 48 of non-interventional follow-up phase, and percentage change from baseline to EOT/week 48 of non-interventional follow-up phase and from EOT to week 48 of non-interventional follow-up phase.

Median (range)	Evaluable patients at EOT (N = 11)	Evaluable patients at week 48 of non-interventional follow-up phase (N = 7)
Sum of volumes at baseline, cm3	119.31 (24.06–861.36)	146.79 (24.06–861.36)
Sum of volumes at EOT, cm3	27.49 (4.03–253.61)	46.63 (4.03–253.61)
Sum of volumes at week 48 of non-interventional follow-up phase, cm3	NA	87.32 (4.96–312.68)
Percentage change from baseline, %	−70.56 (−88.30 to −49.64)	−50.55 (−79.40–23.16)
Percentage change from EOT, %	NA	52.53 (−23.16–87.25)

Abbreviations: EOT = end of treatment; NA = not applicable.